新里程健康科技集团股份有限公司：2025年度拟不进行利润分配的公告详解

关键要点梳理

• 公司2025年度利润分配方案：公司董事会已审议通过2025年度利润分配方案，拟不进行现金分红、不送红股、不以公积金转增股本，方案尚需提交股东大会审议。
• 可供分配利润状况：2025年度实现净利润33,478,753.63元，其中归属于母公司股东的净利润为30,942,846.16元。但截至2025年12月31日，公司未分配利润为-2,934,118,967.04元，母公司未分配利润为-2,880,722,203.24元，均为负数。
• 过去三年利润分配情况：连续三年未进行现金分红，2024年度有回购注销总额50,709,383.98元，其余年份均为零。
• 未触及风险警示条款：公司未触及《深圳证券交易所股票上市规则》第9.8.1条规定的实施其他风险警示情形。

详细内容与投资者关注事项

公司今年实现了正净利润，但由于累计未分配利润长期为负，未能满足现金分红条件。根据审计报告，公司2025年归属于母公司股东的净利润为30,942,846.16元，但未分配利润巨额为负，导致无法进行现金分红或其他利润分配方式。

对股东影响：
1. 连续三年未分红：公司自2023年至2025年连续三年未进行现金分红，2024年仅有回购注销行为。长期未分红可能影响投资者对公司回报的预期，属于潜在价格敏感信息。
2. 累计未分配利润为负：公司、母公司报表均显示累计未分配利润为负，反映公司过去经营亏损未能完全消化，即使今年盈利，仍无法分红。这一状况表明公司财务结构仍需修复，对未来分红能力存在制约。
3. 利润分配原则及限制：公司章程明确规定，只有在未分配利润为正、现金流充足、无重大投资计划等条件下才能分红。当前公司未分配利润为负，因此不具备分红条件。
4. 未来展望：公司强调保障产业持续发展，将继续严格履行利润分配制度，综合考虑债务、资金等因素，致力于健康稳定发展及投资者回报。但短期内分红概率较低，投资者需关注公司财务修复进程。

可能影响股价的因素

• 公司连续三年未分红，且2025年度再次不分红，可能引发投资者失望情绪，影响市场对公司估值。
• 未分配利润巨额为负，表明公司历史亏损仍未消化，可能影响未来分红能力及股价表现。
• 虽然公司未触及风险警示条款，但持续亏损状态需投资者高度关注。

结论

新里程健康科技集团股份有限公司2025年度不进行利润分配，反映了公司财务状况仍需修复。投资者需密切关注公司未来盈利及分红能力，短期内分红预期较弱。此公告为价格敏感信息，建议投资者审慎决策。

免责声明

本文章仅供参考，不构成任何投资建议。投资者应结合自身情况，审慎判断并承担相应风险。

Xinlicheng Health Technology Group Co., Ltd.: Detailed Analysis of No Profit Distribution for 2025

Key Highlights

• 2025 Profit Distribution Proposal: The Board has approved a proposal for no cash dividend, no bonus shares, and no capital reserve conversion for 2025, pending shareholders’ approval.
• Distributable Profit Status: Net profit for 2025 reached RMB 33,478,753.63, with RMB 30,942,846.16 attributable to parent shareholders. However, undistributed profit as of December 31, 2025, was negative: -2,934,118,967.04 for the group and -2,880,722,203.24 for the parent.
• Dividend History: No cash dividends for three consecutive years; only RMB 50,709,383.98 share repurchase in 2024.
• No Risk Warning Triggered: The company does not trigger the risk warning clause under the Shenzhen Stock Exchange Listing Rules (Article 9.8.1).

Details and Investor Concerns

Although the company posted positive net profit in 2025, the accumulated undistributed profit remains heavily negative, disqualifying the company from cash dividend or other profit distribution. As per the audit report, the parent’s net profit is positive, yet overall accumulated losses prevent any payout.

Impact on Shareholders:
1. No Dividend for Three Years: No cash dividend from 2023 to 2025, only a share buyback in 2024. This ongoing lack of payout may disappoint investors and is price-sensitive.
2. Negative Undistributed Profit: Both group and parent company show significant negative undistributed profit, indicating unresolved past losses. Even with current profits, dividends remain out of reach, signaling the need for financial recovery.
3. Dividend Policy Restrictions: Company articles require positive undistributed profit, sufficient cash flow, and no major investment plans for dividends. With negative undistributed profit, payout is not feasible.
4. Future Outlook: The company prioritizes industry development and will strictly follow profit distribution rules, considering debt and cash flow. Short-term dividend prospects remain low; investors should monitor financial recovery.

Potential Share Price Impacts

• Three consecutive years of no dividends, with 2025 again no payout, may trigger investor disappointment and affect valuation.
• Significant negative undistributed profit signals unresolved historical losses, limiting future payout capability and possibly affecting share price.
• Though no risk warning is triggered, continued loss status warrants close investor attention.

Conclusion

Xinlicheng’s no profit distribution for 2025 reflects ongoing financial recovery needs. Investors should closely monitor future profitability and dividend capacity, as short-term dividend expectations are low. This announcement is price-sensitive and warrants careful investor consideration.

Disclaimer

This article is for informational purposes only and does not constitute investment advice. Investors should make prudent decisions based on their own circumstances and assume relevant risks.

View 新里程 Historical chart here